Table 1 Summary of reported patients with clinically significant adverse events
From: Clinically significant adverse events after major ABO mismatch BMT
Patient # | ABO, RhD patient/donor | Volume of incompatible RBCs/patient weight | Rate of infusion of incompatible RBCs | Pre-BMT creatinine | Peak post-infusion creatinine | Clinical management |
|---|---|---|---|---|---|---|
1 | O+/A+ | 1.1 ml/kg | 0.26 ml/kg/h | 0.5 mg/dL | 1.7 mg/dL | infection prophylaxis briefly held, GvHD prophylaxis regimen changed |
2 | O+/B+ | 0.98 ml/kg | 0.21 ml/kg/h | 0.8 mg/dL | 2.8 mg/dL | GvHD prophylaxis regimen changed |
